Optellum, ai lung cancer diagnosis innovator, secures $14m series a funding to accelerate expansion

Lead investor mercia, alongside intuitive ventures and black opal, invests in optellum's pioneering ai-powered lung-health technology oxford, england and houston , sept. 27, 2022 /prnewswire/ -- optellum, an oxford-based medtech company that provides a breakthrough ai platform to diagnose and treat early-stage lung cancer, has raised $14 million in a series a funding round.
ISRG Ratings Summary
ISRG Quant Ranking